Genzyme Company Description
Genzyme makes big money off small-time diseases. The company's product portfolio focuses on rare genetic disorders as well as kidney disease, cancer, and biosurgery. One of its main products, Cerezyme, is a leading (and pricey) treatment for Gaucher's disease, a rare enzyme-deficiency condition. Founded in 1981, Genzyme also is involved in drug development and genetic testing and other services. In addition, the company develops gene-based cancer diagnosis and treatment products, renal care therapies, and orthopedic biological surgery products. Genzyme's products are sold to healthcare professionals in some 100 countries, primarily through wholesale distributors.
View the Comprehensive Company Description for Genzyme
The Company Description provides a historical perspective of Genzyme's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Genzyme's evolution in the marketplace.
